oral vs subcutaneous semaglutide Real-World Use of and in Routine Clinical Practice in the UK: A Single-Centre, Retrospective Observational Study | Diabetes Therapy Research Progress on Oral Semaglutide

The approval makes the UK the first country to authorise an oral version of a GLP-1 weight loss treatment, a drug class already widely used in injectable form

The effects of GLP-1RAs on colorectal and other cancer risk Clinical studies have demonstrated that the use of GLP-1RAs can reduce the risk of colorectal cancer, and the protective effect appears to be positively correlated with the duration of therapy

Bodybuilding or cosmetic use is a separate concern

GLP-1 receptor agonists like semaglutide and tirzepatide work differently

You cannot eliminate nausea entirely, but you can reduce severity through dietary prep and genetic insight